USPTO serial 79229105
DRAQ
Reviewed by CopyMark Law Group
Reg. 5671956Status 739Registered
- Filing date
- Status date
- Registration date
- Feb 12, 2019
- Examiner
- SPARER, KATERINA DOROTHY
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with DRAQ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Leicestershire, GB
Leicestershire, GB
Leicestershire, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nicole M. Meyer
Nicole M. Meyer Dickinson Wright PLLC1825 Eye St. N.W., Suite 900Washington, DC 20006United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic scanning agents for in-vivo use other than for medical or veterinary use; in-vivo diagnostic scanning agents for scientific use; chemicals for use as fluorescent substrates for scientific purposes; chemicals for use in industry and science, namely, fluorescent chemicals; chemicals for use in industry and science, namely, fluorescent substances; chemical preparations for use in DNA analysis other than for medical or veterinary use; chemical substances, chemical materials in the nature of reagents and substrates and chemical preparations for cell-based scientific research; chemical reagent mixtures in kit form for testing, other than for medical or veterinary use; chemical reagent mixtures, other than for medical or veterinary use; chemical reagents for identification of microorganisms, other than for medical or veterinary use; chemical reagents for laboratory use, other than for medical or veterinary use; chemical reagents for molecular biology, other than for medical or veterinary use; chemical reagents for non-medical purposes; chemical reagents for susceptibility determinations, other than for medical or veterinary use; chemical reagents for use in analytical tests, other than for medical or veterinary use; chemical reagents for use in biotechnology, other than for medical or veterinary use; chemical reagents for use in diagnosis, other than for medical or veterinary use; chemical reagents for use in diagnostic tests, other than for medical or veterinary use; chemical reagents for use in industry; chemical reagents for use in science, other than for medical or veterinary use; chemical reagents for use with immunoassay analyzers, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical substances for analysis in laboratories not for medical or veterinary purposes; chemical substances for use in the biotechnological industry, namely, chemical substances for cell-based research; chemical substances for use in bioluminescent processes for scientific purposes; chemical substances for use in the biochemical industry, namely, chemical substances for cell-based research; chemical test reagents other than for medical or veterinary purposes; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemicals for use in immuno-assay testing other than medical or veterinary use; chemicals for use in separation other than for medical or veterinary use; chemicals for use in separation techniques other than medical or veterinary use; chemicals for use in the pharmaceutical industry; chemicals for use in the agrochemical industry; chemicals for use in the manufacture of dyestuffs; chemicals having antimicrobial properties for scientific use other than medical or veterinary use; colorimetric chemicals for scientific purposes; diagnostic chemicals other than for medical or veterinary use; diagnostic reagents and preparations, except for medical or veterinary use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, other than for medical or veterinary use; diagnostic reagents for in-vitro use other than medical or veterinary purposes; diagnostic reagents, except for medical or veterinary use; diagnostic reagents for scientific purposes, other than for medical laboratory use; diagnostic reagents, other than for medical or veterinary use for sale in kit form; diagnostic scanning agents for in-vivo use other than for medical or veterinary purposes; diagnostic substances, other than for medical or veterinary use; diagnostic testing materials, other than for medical use being diagnostic preparations for scientific use; fine chemicals for use in industry; fluorescent chemicals for use in cell-based research for scientific purposes; fluorescent chemicals for use as a fluorescent label for scientific purposes; chemicals used in industry, namely, fluorescent labels for nucleotides and proteins; fluorescent substances, namely, fluorescent dye for scientific or research use; reagents for analytical purposes other than for medical or veterinary purposes; reagents for bacteriological analysis of culture water other than for medical or veterinary purposes; reagents for scientific use, namely, reagents for chemical analyses; reagents for in-vitro laboratory use other than for medical or veterinary purposes; reagents for industrial purposes; reagents for laboratory purposes other than for medical or veterinary purposes; reagents for medical research; reagents for microbiological analysis other than for medical or veterinary purposes; reagents for research purposes; reagents for scientific or medical research use; reagents for testing aqueous solutions other than for medical or veterinary purposes; reagents for testing water; reagents for testing the sterility of medical equipment; reagents for research purposes, namely, reagents for testing the sterility of pharmaceuticals and injectable solutions; reagents for use in analytical tests other than for medical or veterinary purposes; reagents for use in analysis other than for medical or veterinary purposes; reagents for use in biological processing other than for medical or veterinary purposes; reagents for use in diagnostic tests other than for medical or veterinary purposes; reagents for use in environmental analysis for scientific and research purposes; reagents for use in environmental testing for scientific and research purposes; reagents for use in medical research, namely, reagents for use in immunoserology research; reagents for use in scientific apparatus for chemical or biological analysis; reagents for use in the development of hybridoma antibodies other than for medical or veterinary purposes; reagents for use in the development of monoclonal antibodies other than for medical or veterinary purposes; reagents for use with analyzers other than for medical or veterinary purposes; reagents in kit form for conducting enzyme-linked immunosorbent assays (ELISA) other than for medical or veterinary purposes; test reagents other than for medical or veterinary use; testing reagents for industrial use; water testing chemicals for testing drinking water | ACTIVE | — |
| 005 | Medical and veterinary preparations and articles, namely, biological preparations for use as diagnostic agents for medical and veterinary purposes; diagnostic preparations for medical purposes; chemical preparations in the nature of reagents for testing blood for medical purposes; chemical preparations in the nature of reagents for use in DNA analysis for medical purposes; chemical reagents for medical or veterinary purposes; chemical reagents for medical use; chemical reagents for veterinary use; chemical test reagents for medical use; chemical test reagents for veterinary use; clinical diagnostic reagents; clinical medical reagents; diagnostic reagents for medical use; diagnostic substances for medical use, namely, diagnostic reagent for medical and diagnostic purposes; diagnostic testing materials in the nature of diagnostic preparations for medical use; immunoassay reagents for medical use; in vitro diagnostic preparations for medical use; medical diagnostic reagents and assays for testing of body fluids; diagnostic agents for medical use; diagnostic agents for medical purposes, namely, diagnostic agents for pharmaceutical use; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic preparations for medical or veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; reagents for analytical purposes for medical purposes; reagents for analytical purposes for veterinary purposes; reagents for in-vitro laboratory use for medical purposes; reagents for in-vitro laboratory use for veterinary purposes; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for use in analysis for medical purposes; reagents for use in analysis for veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use in diagnostic tests for veterinary purposes; veterinary diagnostic reagents | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 16, 2025 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Apr 16, 2025 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Apr 14, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 25, 2024 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jun 28, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 6, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 6, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 12, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 12, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 27, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 24, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 7, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 7, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 7, 2018 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 25, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 23, 2018 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Oct 23, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 23, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 23, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 19, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 19, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 17, 2018 | ALIE | ASSIGNED TO LIE | — |
| Oct 8, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 27, 2018 | RFNP | REFUSAL PROCESSED BY IB | — |
| Apr 10, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 10, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 4, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 3, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 31, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 27, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 27, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 22, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |